AstraZeneca will be too late — COVID's death toll — Variant shot trial starts

 
Subscribe to Insider View in browser
 
 
 
INSIDER HEALTHCARE
 
 
 
 

Hello,

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments or tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Now, let's get to it...


More news about the Pfizer vaccine this morning: In new data released Thursday, the company said its vaccine with BioNTech is holding up after six months. The two-dose vaccine is 91% effective at preventing symptomatic COVID-19.

Get the latest on the data here>>


astrazeneca

AstraZeneca's COVID-19 shot will come too late for the US

Get the full analysis here>>


COVID-19 swab

COVID-19 was the 3rd leading cause of death in the US for all of 2020

Find out more here>>


Coronavirus vaccine Moderna trial college students transmission study

The US just launched the first study testing a version of Moderna's coronavirus vaccine tailored to fight a concerning variant

Check it out>>


More stories we're reading:


- Lydia

 
 
 
 
 
INSIDER

Was this email forwarded to you?
 
Download on the app store   Get it on google play
 
You received this email because you signed up to this
Insider newsletter using the
email: aymentanaze.news@blogger.com
 
Email preferences Unsubscribe
TERMS OF SERVICE PRIVACY POLICY
1 Liberty Plaza, 8th Floor. New York, NY 10006
 

Commentaires

Posts les plus consultés de ce blog

Chris Ramsey can take the heat, but what would relegation for QPR mean for black managers in the Premier League?

How a team of innovators overcame the odds to create water from thin air

Britain's health service uses long Twitter thread to explain why it needs more black people to donate blood